News

How to make Medicare Advantage plans attractive by meeting the needs of a new generation of senior patients.

Five surprising updates about one of healthcare’s top trends.

A Commonwealth Fund study has revealing findings about PBMs’ use of rebates and impact on drug prices.

How technologies are helping health systems think about-and mobilize on-social determinants of health.

Healthcare experts weigh in on what we can expect in 2019 and beyond.

The real-world strategies used to manage the high cost of specialty meds.

The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?

Metastatic breast cancer drug expands treatment to men.

A complex disease such as diabetes requires a team-based approach to help patients comply with their regimen.

After his mother’s journey with breast cancer, Scott Rissmiller discovered the deep desire to make an impact in others’ lives as a physician-leader.

While it is difficult work, provider engagement is attainable. Here are some strategies that health systems can use to successfully engage their physicians.

What health execs need to know about the drugs and policies affecting spending.

The disease management and insurer initiatives changing the diabetes landscape.

FDA fast-tracks biosimiliar insulin products to elevate competition.

Industry groups are calling for clear FDA guidance on language used by biologic originators to protect market share.

What the future of specialty drugs holds for healthcare.

Gene therapy offers great hope for patients, but comes with a bevy of challenges for patients and payers alike.

FDA approved 2 new multiple sclerosis drugs. Here's what you should know about them.

A new HHS proposal could do away with-or at least forever change-PBM drug rebates. Here’s what that could mean for health execs.

How over-the-counter meds keep patients healthier.

A new study has revealing findings about the progress on population health objectives.

The mistakes hospitals are making-and what they can do.

While the Democratic House and Democratic presidential candidates tout Medicare for All, opposing forces are also at work.

The tools and processes one of the largest not-for-profit Medicare Advantage plans uses to help seniors.

Postpartum drug is a game changer, but can women afford it?

Several companies are recalling products due to contamination from substances such as carcinogens and glass-here’s what you should know.

The ONC and CMS medical information transparency rule for patients, providers, and insurers may be the biggest change in healthcare system operations since the ACA. Here’s what to expect.